sglt2 inhibitors and glp 1 receptor agonists GLP-1 Agonists: Which is the Best Blood Pressure-Lowering Effects of SGLT2

First, the lower levels of active incretin compared to healthy subjects due to the increased degradation by dipeptidyl peptidase-4 and reduced incretin production in patients with NAFLD may explain the beneficial effect of GLP-1RA in NAFLD treatment [44]

Users report weight loss and a reduction in blood sugar spikes

N Engl J Med (2020) 383(12):111728

Patients treated with GLP-1RA will need to self-inject agents or have them administered subcutaneously anywhere from twice daily to once weekly depending on formulation

This expands your patient pool

This occurs via the signaling pathways of IL-10/IL-10 receptor-/STAT3 and cAMP/PKA/p38/CREB [112]